tiprankstipranks
Advertisement
Advertisement

XVIPF Stock Latest News

XVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
Company AnnouncementsXVIVO Perfusion Calls 2026 AGM, Proposes New Board Members and Incentive Plan
22d ago
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
PremiumCompany Announcements
XVIVO Perfusion Updates Board Proposals Ahead of 2026 AGM
2M ago
XVIVO Perfusion nominates experienced healthcare leaders to strengthen board
PremiumCompany Announcements
XVIVO Perfusion nominates experienced healthcare leaders to strengthen board
2M ago
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
PremiumCompany Announcements
XVIVO Elevates CFO to Lead Global Strategy as It Targets U.S. Growth
2M ago
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
PremiumCompany Announcements
XVIVO Delays Q1 2026 Report to Spotlight Key U.S. Heart Study
2M ago
XVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
PremiumCompany AnnouncementsXVIVO Perfusion Balances Organ Business Growth With Heavy R&D Spend in 2025
2M ago
XVIPF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
XVIPF Earnings this Week: How Will it Perform?
3M ago
XVIVO Schedules Conference Call for 2025 Year-End Results
Premium
Company Announcements
XVIVO Schedules Conference Call for 2025 Year-End Results
3M ago
XVIVO CEO to Spotlight Organ-Transplant Technology at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
XVIVO CEO to Spotlight Organ-Transplant Technology at J.P. Morgan Healthcare Conference
3M ago
XVIVO Perfusion’s Heart Preservation Study: A Potential Game-Changer for Transplants
PremiumCompany Announcements
XVIVO Perfusion’s Heart Preservation Study: A Potential Game-Changer for Transplants
5M ago
XVIPF
Xvivo Perfusion AB’s DeLIVER Trial: A Promising Step in Liver Transplantation
PremiumCompany Announcements
Xvivo Perfusion AB’s DeLIVER Trial: A Promising Step in Liver Transplantation
5M ago
XVIPF
Xvivo Perfusion’s New Heart Transport Study: A Potential Game Changer?
PremiumCompany Announcements
Xvivo Perfusion’s New Heart Transport Study: A Potential Game Changer?
5M ago
XVIPF
Xvivo Perfusion AB’s Mixed Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsXvivo Perfusion AB’s Mixed Earnings Call: Growth Amid Challenges
6M ago
Xvivo Perfusion upgraded to Buy from Hold at Danske Bank
Premium
The Fly
Xvivo Perfusion upgraded to Buy from Hold at Danske Bank
6M ago
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Financial Results for 2025
6M ago
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
PremiumCompany Announcements
XVIVO Perfusion AB Reports Mixed Financial Results Amid Strategic Investments
6M ago
XVIPF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
XVIPF Earnings this Week: How Will it Perform?
6M ago
Xvivo Perfusion reports CE approval delay for perfusion solution and supplement
PremiumThe Fly
Xvivo Perfusion reports CE approval delay for perfusion solution and supplement
9M ago
XVIVO Faces Delay in CE Approval for Heart Perfusion Solution
PremiumCompany Announcements
XVIVO Faces Delay in CE Approval for Heart Perfusion Solution
9M ago
XVIVO Initiates US PRESERVE CAP Study for Heart Assist Device
PremiumCompany AnnouncementsXVIVO Initiates US PRESERVE CAP Study for Heart Assist Device
9M ago
Xvivo Perfusion upgraded to Buy from Hold at DNB Carnegie
Premium
The Fly
Xvivo Perfusion upgraded to Buy from Hold at DNB Carnegie
9M ago
XVIVO Perfusion AB Reports Mixed Results Amid Strategic Growth
Premium
Company Announcements
XVIVO Perfusion AB Reports Mixed Results Amid Strategic Growth
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >